Abstract
Minimally invasive energy-based ablation techniques such as radiofrequency ablation, cryoablation, and irreversible electroporation are now widely used for treatment of a variety of malignant lesions. An unexpected but interesting sequel of such ablation methods has been regression of untreated distant metastases following ablation of the primary lesion. This phenomenon has been fairly studied following ablation with hypo- and hyperthermal modalities, especially cryoablation, and is mostly ascribed to an adaptive antitumor immune response induced by release of significant quantities of normally inaccessible tumor antigens from the damaged tissue. Irreversible electroporation is a new, nonthermal ablation technology that because of its unique characteristics is hypothesized to be capable of inciting a strong tumor-specific adaptive immune response. However, very limited information regarding existence, extent, and efficacy of such immune response is available in the literature. Therefore, based on literature pertaining to other energy-based techniques, this chapter first provides a brief summary of mechanisms proposed to be involved in the interaction between immune system and tissue ablation methods. Then, data from studies investigating the local and systemic immune response following IRE will be presented and analyzed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbas AK, Lichtman AH, Pillai S (2015) Cellular and molecular immunology, 8th edn. Elsevier Saunders, Philadelphia
Ahmed M, Brace CL, Lee FT Jr, Goldberg SN (2011) Principles of and advances in percutaneous ablation. Radiology 258(2):351–369
Al-Sakere B, Andre F, Bernat C et al (2007a) Tumor ablation with irreversible electroporation. PLoS One 2(11):e1135
Al-Sakere B, Bernat C, Andre F et al (2007b) A study of the immunological response to tumor ablation with irreversible electroporation. Technol Cancer Res Treat 6(4):301–306
Bastianpillai C, Petrides N, Shah T, Guillaumier S, Ahmed HU, Arya M (2015) Harnessing the immunomodulatory effect of thermal and non-thermal ablative therapies for cancer treatment. Tumour Biol 36(12):9137–9146
Chu KF, Dupuy DE (2014) Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer 14(3):199–208
Curtsinger JM, Lins DC, Mescher MF (2003) Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J Exp Med 197(9):1141–1151
Fuchs EJ, Matzinger P (1996) Is cancer dangerous to the immune system? Semin Immunol 8(5):271–280
Haen SP, Pereira PL, Salih HR, Rammensee HG, Gouttefangeas C (2011) More than just tumor destruction: immunomodulation by thermal ablation of cancer. Clin Dev Immunol 2011:160250
Lee EW, Chen C, Prieto VE, Dry SM, Loh CT, Kee ST (2010) Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology 255(2):426–433
Lee EW, Wong D, Prikhodko SV et al (2012) Electron microscopic demonstration and evaluation of irreversible electroporation-induced nanopores on hepatocyte membranes. J Vasc Interv Radiol 23(1):107–113
Li M, Zhang S, Zhou Y, Guo Y, Jiang X, Miao L (2010) Argon-helium cryosurgery for treatment of C6 gliomas in rats and its effect on cellular immunity. Technol Cancer Res Treat 9(1):87–94
Li X, Xu K, Li W et al (2012) Immunologic response to tumor ablation with irreversible electroporation. PLoS One 7(11):e48749
Machlenkin A, Goldberger O, Tirosh B et al (2005) Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity. Clin Cancer Res 11(13):4955–4961
Matzinger P (1994) Tolerance, danger, and the extended family. Annu Rev Immunol 12:991–1045
Murakami S (2004) Soluble interleukin-2 receptor in cancer. Front Biosci 9:3085–3090
Neal RE 2nd, Rossmeisl JH Jr, Robertson JL et al (2013) Improved local and systemic anti-tumor efficacy for irreversible electroporation in immunocompetent versus immunodeficient mice. PLoS One 8(5):e64559
Onik G, Mikus P, Rubinsky B (2007) Irreversible electroporation: implications for prostate ablation. Technol Cancer Res Treat 6(4):295–300
Peng Y, Martin DA, Kenkel J, Zhang K, Ogden CA, Elkon KB (2007) Innate and adaptive immune response to apoptotic cells. J Autoimmun 29(4):303–309
Pereira PL (2007) Actual role of radiofrequency ablation of liver metastases. Eur Radiol 17(8):2062–2070
Scheffer SR, Nave H, Korangy F et al (2003) Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo. Int J Cancer 103(2):205–211
Thomson KR, Cheung W, Ellis SJ et al (2011) Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol 22(5):611–621
Unitt E, Marshall A, Gelson W et al (2006) Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation. J Hepatol 45(2):246–253
Viorritto ICB, Nikolov NP, Siegel RM (2007) Autoimmunity versus tolerance: can dying cells tip the balance? Clin Immunol 122(2):125–134
Wagstaff PG, Buijs M, van den Bos W et al (2016) Irreversible electroporation: state of the art. Onco Targets Ther 9:2437–2446
Zerbini A, Pilli M, Penna A et al (2006) Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses. Cancer Res 66(2):1139–1146
Zhou W, Xiong Z, Liu Y, Yao C, Li C (2012) Low voltage irreversible electroporation induced apoptosis in HeLa cells. J Cancer Res Ther 8(1):80–85
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this entry
Cite this entry
Tafti, B.A., Kee, S.T. (2017). Immunological Response to Electroporation. In: Miklavčič, D. (eds) Handbook of Electroporation. Springer, Cham. https://doi.org/10.1007/978-3-319-32886-7_170
Download citation
DOI: https://doi.org/10.1007/978-3-319-32886-7_170
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32885-0
Online ISBN: 978-3-319-32886-7
eBook Packages: EngineeringReference Module Computer Science and Engineering
